Prevalence of Transmitted HIV Drug Resistance Among Newly Diagnosed Antiretroviral Therapy–Naive Pregnant Women in Lilongwe and Blantyre, Malawi
- 15 May 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 54 (suppl_4) , S324-S327
Abstract
In 2006, a survey of transmitted human immunodeficiency virus (HIV) drug resistance (TDR) was conducted in Lilongwe, Malawi. The survey followed the World Health Organization method to classify TDR to nucleoside reverse transcriptase inhibitors (NRTIs), nonnucleoside reverse transcriptase inhibitors (NNRTIs), and protease inhibitors (PIs) among primigravid women aged <25 years. Results of the 2006 survey showed <5% TDR in all drug classes. In 2009, TDR surveys using the same method were repeated in Lilongwe and expanded to Blantyre. Findings show that in Lilongwe TDR to NRTIs and PIs was <5%, whereas TDR to NNRTIs was 5%-15%. In Blantyre, TDR was <5% to all drug classes. Observed moderate TDR in Lilongwe is cause for concern and signals the need for closer monitoring of Malawi's antiretroviral therapy program.Keywords
This publication has 17 references indexed in Scilit:
- Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatmentAntiviral Therapy, 2008
- A novel sequential sampling technique for the surveillance of transmitted HIV drug resistance by cross-sectional survey for use in low resource settingsAntiviral Therapy, 2008
- Surveillance of transmitted HIV drug resistance among women attending antenatal clinics in Dar es Salaam, TanzaniaAntiviral Therapy, 2008
- Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004Antiviral Therapy, 2008
- Molecular Epidemiology of HIV Type 1 in Treatment-Naive Patients in North EthiopiaAIDS Research and Human Retroviruses, 2007
- Surveillance of transmitted HIV drug resistance with the World Health Organization threshold survey method in Lilongwe, MalawiAntiviral Therapy, 2007
- Threshold survey evaluating transmitted HIV drug resistance among public antenatal clinic clients in Addis Ababa, EthiopiaAntiviral Therapy, 2007
- Resistance Mutational Analysis of HIV Type 1 Subtype C among Rural South African Drug-Naive Patients Prior to Large-Scale Availability of AntiretroviralsAIDS Research and Human Retroviruses, 2006
- An automated genotyping system for analysis of HIV-1 and other microbial sequencesBioinformatics, 2005
- Clinical Use of Genotypic and Phenotypic Drug Resistance Testing to Monitor Antiretroviral ChemotherapyClinical Infectious Diseases, 2001